Zobrazeno 1 - 10
of 20
pro vyhledávání: '"D. P. Lynam"'
Autor:
D. P. Lynam
Publikováno v:
Journal of Cardiothoracic Anesthesia. 4:20-23
The effective dosages, onset times, and durations of action for doxacurium when administered to either adults or children during various types of anesthetics are discussed. In general children require more doxacurium to achieve and maintain a given d
Autor:
Edmond I. Eger, Michael J. Laster, James E. Caldwell, Toni Magorlan, Nobuhlku Yasuda, Richard B. Weiskopf, D. P. Lynam, Tom Heler
Publikováno v:
Anesthesiology. 74(3)
The neuromuscular effects of desflurane administered alone were studied in ten healthy human volunteers aged 20-27 yr. Also, the dose-response relationships of pancuronium and succinylcholine in surgical patients during anesthesia with desflurane (n
Publikováno v:
Anesthesiology. 73(3)
The authors sought to determine whether neostigmine, given at a time when no response to peripheral nerve stimulation could be elicited, hastened recovery from a vecuronium-induced neuromuscular blockade (NMB). The effect of neostigmine (70 microgram
Autor:
Edmond I. Eger, Ronald D. Miller, T. Magorian, D. P. Lynam, Veronica Segredo, James E. Caldwell
Publikováno v:
Anesthesiology. 73
Autor:
D. P. Lynam, Mark R. Fahey, Ronald D. Miller, P.C. Canfell, K.P. Castagnoli, Dennis M. Fisher, James E. Caldwell
Publikováno v:
British Journal of Anaesthesia. 61:693-697
The pharmacokinetics of pipecuronium 0.07 mg kg−1 and pancuronium 0.1 mg kg−1 were compared in 39 ASA class I or II patients. Plasma concentrations of these agents were measured for 6 h following administration, using a sensitive and specific cap
Autor:
John C. Cannon, James Arden, Ronald D. Miller, D. P. Lynam, Kay Castagnoli, P. Claver Canfell
Publikováno v:
Anesthesiology. 68:771-776
To determine the effect of alcoholic liver disease on the pharmacokinetics and pharmacodynamics of vecuronium, the authors administered vecuronium 0.1 mg.kg-1 iv to ten surgical patients with alcoholic liver disease and ten healthy surgical patients.
Publikováno v:
Anesthesiology. 68(5)
To determine the effect of alcoholic liver disease on the pharmacokinetics and pharmacodynamics of vecuronium, the authors administered vecuronium 0.1 mg.kg-1 iv to ten surgical patients with alcoholic liver disease and ten healthy surgical patients.
Autor:
James E. Caldwell, Mark R. Fahey, P. Claver Canfell, Dennis M. Fisher, Kay P. Castagnoll, Ronald D. Miller, D. P. Lynam
Publikováno v:
Anesthesiology. 70(1)
The authors determined the pharmacokinetics and duration of action of a bolus dose of pipecuronium bromide (0.07 mg.kg-1) in 40 patients anesthetized with halothane and nitrous oxide. Twenty were patients with normal renal function, undergoing a vari
Autor:
P.C. Canfell, D. P. Lynam, Ronald D. Miller, Kay Castagnoli, James Arden, Roy Cronnelly, James E. Caldwell
Publikováno v:
Anesthesiology. 69(2)
The duration of action and the pharmacokinetics of vecuronium were compared in patients with and without renal function. Twenty patients were studied: 12 with renal failure who were to receive kidney transplants from cadaveric donors, and eight with
Publikováno v:
British journal of anaesthesia. 63(4)
We compared the neuromuscular and cardiovascular changes following administration of mivacurium 0.15, 0.20 and 0.25 mg kg-1, suxamethonium 1.0 mg kg-1 or atracurium 0.5 mg kg-1 i.v. in 41 (ASA physical status I or II) patients during nitrous oxide-fe